56. Teva Pharmaceutical Industries
Rank: 56 (Previous rank: N.A.)
CEO: Shlomo Yanai
Address: 5 Basel St.
Petah Tikva, Israel 49131
King of the generic-drug makers acquired rival Barr Pharmaceuticals.
|
|
$ millions (past 4 qtrs.) |
% growth (3 yr. annual rate) |
Growth rank |
Revenues** |
11,660.0 |
25 |
88 |
Net income** |
939.0 |
— |
— |
Total return |
— |
16 |
44 |
Earnings per share |
— |
61 |
37 |
Share price |
|
As of 8/3/09 |
$53.58 |
Beat the S&P 500* |
Yes |
P/E (current fiscal year est.) |
16 |
Industry rank |
Company |
Fastest-Growing rank |
Revenues ($ millions) |
1 |
Bruker |
9 |
1,099.2 |
2 |
HMS Holdings |
20 |
195.5 |
3 |
Celgene |
22 |
2,397.2 |
From the August 31, 2009 issue
|
|
See Teva Pharmaceutical Industries in...
|